← Home / Aquestive Therapeutics, Inc. (AQST)
Stock Analysis
Aquestive Therapeutics, Inc. (AQST)
AQST
AQST · Market data
4.43 +3.99%
52W Range Position
33%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-06-18 13:42 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 4.89. Holding above 4.37 keeps the current thesis intact.
⚖️
Fundamentals
Strong / Strong
Price Structure
Mixed
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
4.37
Break Above
Confirmation improves above resistance.
4.89
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 4.37
What's Driving AQST?
📈 Technical recovery is improving
Momentum is Neutral. Watch 4.89 for confirmation and 4.37 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 4.37 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
62.5
How to read this setup
The next meaningful technical decision is likely to occur between support at 4.37 and resistance at 4.62. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
AQST · WOI overlay chart
Open Full Workspace
Business Lens
Financial context is mixed
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
Revenue Growth
Strong
Profitability
Strong
Cash Flow
Mixed
Balance Sheet
Manageable
💵 Revenue
14.45M
↗ Strong
📈 Net Income
-8.06M
↗ Strong
🧮 EPS (Basic)
-0.07
↗ Strong
Aquestive Therapeutics, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.